Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Wettergren

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Oncogene|October 25, 2011
p37δ is a new isoform of PI3K p110δ that increases cell proliferation and is overexpressed in tumorsS Fransson, A Uv, H Eriksson, et al.
International Journal of Oncology|July 25, 2012
Genomic CGH-assessed structural DNA alterations in rectal carcinoma as related to local recurrence following primary operation for cureK Kodeda, A Gustafsson Asting, C Lönnroth, et al.
The Pharmacogenomics Journal|August 12, 2015
AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatinJ B Kjersem, M Thomsen, T Guren, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 22, 2018
Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancerA K Boysen, B S Sørensen, A C Lefevre, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Oncogene|October 25, 2011
p37δ is a new isoform of PI3K p110δ that increases cell proliferation and is overexpressed in tumorsS Fransson, A Uv, H Eriksson, et al.
International Journal of Oncology|July 25, 2012
Genomic CGH-assessed structural DNA alterations in rectal carcinoma as related to local recurrence following primary operation for cureK Kodeda, A Gustafsson Asting, C Lönnroth, et al.
The Pharmacogenomics Journal|August 12, 2015
AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatinJ B Kjersem, M Thomsen, T Guren, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 22, 2018
Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancerA K Boysen, B S Sørensen, A C Lefevre, et al.
Pageof 2